Super-DMZ Rx 2 — Class I drug recall D-1150-2014
Terminated recall by Mira Health Products Ltd., reported 2014-03-12, distributed nationwide. Marketed without an Approved NDA/ANDA; product contains the steroid ingredient 2, 17a-dimethyl-17b-hydroxy-5a-
| Recall number | D-1150-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mira Health Products Ltd., Farmingdale, NY, United States |
| Recall initiated | 2013-07-22 |
| Classified | 2014-03-05 |
| Reported by FDA | 2014-03-12 |
| Terminated | 2014-09-15 |
| Distributed | Nationwide (US) |
| Reason classes | unapproved product |
| Expiration dates | 2016-04 |
Product
Super-DMZ Rx 2.0 Capsules, 60 count bottles, Dietary Supplement, Lean muscle mass, hardness and strength, Manufactured for Blackstone Labs Boca Raton, FL 33433.
Reason for recall
Marketed without an Approved NDA/ANDA; product contains the steroid ingredient 2, 17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one, making it an unapproved new drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1150-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.